| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/04/2011 | US20110190341 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 08/04/2011 | US20110190339 6-substituted isoquinolines and isoquinolinones |
| 08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 08/04/2011 | US20110190309 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST |
| 08/04/2011 | US20110190303 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 08/04/2011 | US20110190302 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use |
| 08/04/2011 | US20110190292 Heterobicyclic compounds useful as kinase inhibitors |
| 08/04/2011 | US20110190284 Aerosol formulations for the inhalation of beta-agonists |
| 08/04/2011 | US20110190277 Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 08/04/2011 | US20110190274 Salt of, and processes for the preparation of, 1-isopropyl-4-hexahydro-1h-1,4-diazepine |
| 08/04/2011 | US20110190260 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190252 Compositions including clavulanic acid and related methods of use |
| 08/04/2011 | US20110190249 Therapeutic methods and uses of sapogenins and their derivatives |
| 08/04/2011 | US20110190248 Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 08/04/2011 | US20110190247 Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| 08/04/2011 | US20110190245 Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safety |
| 08/04/2011 | US20110190240 Nuclear factor kappa b pathway inhibitor composition and use of same |
| 08/04/2011 | US20110190238 Modifications of solid 3-sn-phosphoglycerides |
| 08/04/2011 | US20110190237 Macrocyclic Prodrug Compounds Useful as Therapeutics |
| 08/04/2011 | US20110190227 Antagonists of Prostaglandin D2 Receptors |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110189274 Stable Pharmaceutical Compositions Of Montelukast Or Its Salts Or Solvates Or Hydrates |
| 08/04/2011 | US20110189240 Microencapsulated compositions for endoluminal tissue engineering |
| 08/04/2011 | US20110189220 Mushroom compositions and methods for making and using |
| 08/04/2011 | US20110189212 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
| 08/04/2011 | US20110189167 Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases |
| 08/04/2011 | US20110189166 Methods of treating hemorheologic abnormalities in mammals |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/04/2011 | US20110189104 Surfactant protein d for the treatment of disorders associated with lung injury |
| 08/04/2011 | US20110189082 Human gm-csf antigen binding proteins |
| 08/04/2011 | CA2788364A1 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof |
| 08/04/2011 | CA2788326A1 Compounds for use in the treatment of diseases |
| 08/04/2011 | CA2788078A1 Compositions and methods for prevention and treatment of pulmonary hypertension |
| 08/04/2011 | CA2784571A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | CA2781314A1 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 08/04/2011 | CA2761509A1 Triazine-aryl-bis-indoles and process for preparation thereof |
| 08/03/2011 | EP2351832A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same |
| 08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
| 08/03/2011 | EP2351754A1 Phenanthroindolizidine compound and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351753A1 Phenanthroindolizidine derivative and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 08/03/2011 | EP2351566A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 08/03/2011 | EP2351563A1 Agent for treatment of diabetes |
| 08/03/2011 | EP2350264A2 Treatment of chronic inflammatory respiratory disorders |
| 08/03/2011 | EP2350059A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 08/03/2011 | EP2350049A2 P38 map kinase inhibitors |
| 08/03/2011 | EP2350047A2 P38 map kinase inhibitors |
| 08/03/2011 | EP2349295A1 Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains |
| 08/03/2011 | EP2349290A1 Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension |
| 08/03/2011 | EP2349282A2 Methods of treating pulmonary disorders with liposomal amikacin formulations |
| 08/03/2011 | EP2349274A1 Folate receptor binding conjugates of antifolates |
| 08/03/2011 | EP2349256A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 08/03/2011 | EP2349209A2 Nanoemulsion therapeutic compositions and methods of using the same |
| 08/03/2011 | EP2349206A2 Corticosteroid compositions and methods of treatments thereof |
| 08/03/2011 | EP2152674B1 Benzimidazolone chymase inhibitors |
| 08/03/2011 | EP2114970B1 Tricyclic compounds and their use as glucocorticoid receptor modulators |
| 08/03/2011 | EP1534753B1 Peg positional isomer of an anti-tnfalpha antibody (cdp870) |
| 08/03/2011 | EP1391202B1 Liquid drug preparations |
| 08/03/2011 | CN1898240B Imidazopyrazine tyrosine kinase inhibitors |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102140104A 1-(3-(S)-amino propyl)-piperidine-4-aminoacid amide compound and pharmaceutical composition thereof as well as preparation methods and applications of compound and pharmaceutical composition |
| 08/03/2011 | CN102139105A Immunotherapy method |
| 08/03/2011 | CN102139078A Traditional Chinese medicine for treating pulmonary diseases |
| 08/03/2011 | CN102139068A Traditional Chinese medicine for treating cough in children |
| 08/03/2011 | CN102139067A Quality control method for antipyretic and antitoxic tablet |
| 08/03/2011 | CN102139062A Novel traditional Chinese medicine for treating pharyngitis and tonsillitis |
| 08/03/2011 | CN102139058A Traditional Chinese medicine for treating stomach diseases |
| 08/03/2011 | CN102139052A Disease-prevention and healthcare Chinese medicinal preparation for breeding pig |
| 08/03/2011 | CN102139051A Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia |
| 08/03/2011 | CN102139050A Chinese medicinal formula for treating dry cough |
| 08/03/2011 | CN102139047A Preparation method of capsule containing snake gall and Sichuan fritillary bulbs |
| 08/03/2011 | CN102139045A Quality control method for Xiebai syrup |
| 08/03/2011 | CN102139040A Quality control method of tablet capable of clearing lung and inhibiting fire |
| 08/03/2011 | CN102139039A Quality control method of coptis tablet for clearing away stomach heat |
| 08/03/2011 | CN102139023A Health-care tobacco-control type Chinese medicinal herb sucking product and preparation method |
| 08/03/2011 | CN102139020A Medicament for treating influenza and bad cold and preparation method thereof |
| 08/03/2011 | CN102139008A Quality control method of Xiaoer daochi tablet |
| 08/03/2011 | CN102139002A Cortex phellodendri polysaccharide extract and preparation method and medical application thereof |
| 08/03/2011 | CN102138996A Honey pomelo peel processing powder |
| 08/03/2011 | CN102138988A Medicinal liquor having functions of tonifying qi and relieving asthma |
| 08/03/2011 | CN102138978A Quality control method for mongolian dandelion herb corydalis and indigowoad root-containing inflammation diminishing tablets |
| 08/03/2011 | CN102138977A Baizhi Xiner decoction for adenoid vegetation |
| 08/03/2011 | CN102138975A Formula of medicine for treating rhinitis |
| 08/03/2011 | CN102138963A Chinese angelica and astragalus extract, and preparation method and application thereof |
| 08/03/2011 | CN102138902A Inhalation composition |
| 08/03/2011 | CN102138611A Natural plant herbal tea and preparation method and use thereof |
| 08/03/2011 | CN101837047B Method for preparing concentrated Yinhuang oral liquid |
| 08/03/2011 | CN101816706B Chinese traditional medicament valid target composition for treating viral respiratory infection diseases |
| 08/03/2011 | CN101716215B Quality detection method of traditional Chinese medicine of isatis root |
| 08/03/2011 | CN101361737B Use of 4-tetrahydrothiazole dione derivates |
| 08/03/2011 | CN101253180B 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands |
| 08/03/2011 | CN101095836B Decoction medicine for treating chronic bronchitis and method for preparing the same |
| 08/03/2011 | CN101095834B Decoction medicine for treating aypnia fantod type chronic bronchitis |
| 08/02/2011 | US7989602 Synthetic molecules having immune activity |
| 08/02/2011 | US7989478 Cinnamoyl compound and use of the same |
| 08/02/2011 | US7989459 Purinones and 1H-imidazopyridinones as PKC-theta inhibitors |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2488242C Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |